Ankylosing Spondylitis Patients Report Improved Quality of Life with Bimekizumab
Tracking Bone Deterioration in Patients with Ankylosing Spondylitis
Ixekizumab Promising for AS; Plus Certolizumab Pegol Studied for Psoriasis
Ankylosing Spondylitis: A Patient’s Perspective
Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab
MIF Cytokine May Impact Inflammation, Bone Formation in Ankylosing Spondylitis
Rheumatology Drug Updates: Efficacy Studied Following Accelerated Drug Approvals; Plus Secukinumab Meets Benchmark for Psoriasis
Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab
Secukinumab Meets 5-Year Benchmark for Psoriasis
- 1
- 2
- 3
- …
- 7
- Next Page »